Intrinsic Value of S&P & Nasdaq Contact Us

GelStat Corporation GSAC OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

GelStat Corporation (GSAC) reported total assets of $319.49K and total liabilities of $1.52M for quarter ending 2025-06-30, resulting in total equity of $-1.2M.

The company held $71.41K in cash and short-term investments. Total debt stood at $849.62K, with net debt of $839.99K. The Debt-to-Equity (D/E) ratio was -0.71 (conservative).

Current ratio is 0.3, which may signal tight short-term liquidity. Interest coverage is -3x (weak).

Criteria supported by this page:

  • HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
  • MOAT (50/100) — Total assets $319.49K and equity $-1.2M support the company's competitive scale

Overall SharesGrow Score: 22/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
24/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
50/100
Proven by this page
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income
GelStat Corporation Balance Sheet History
Metric Q2 FY2025 Q4 FY2024 Q3 FY2024 Q2 FY2024
Total Assets $319.49K$170.89K$170.89K$172.59K
Total Liabilities $1.52M$1.22M$1.22M$1.19M
Total Debt $849.62K$664.56K$664.56K$596.8K
Cash & Investments $71.41K$8.83K$8.83K$6.67K
Total Stockholders Equity $-1.2M$-1.05M$-1.05M$-1.02M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message